Skip to main content Skip to section navigation Skip to footer

Mydecine Innovations Group Inc.

  • Home
  • About
    • Overview
    • Company History
    • Acquisitions
    • Partnerships
    • Leadership Team
    • Board of Directors
    • Research & Development Team
    • Medical, Scientific and Technology Advisory Board
  • Our Approach
    • IP & Drug Development
    • Clinical Trials
    • Technology
  • Drug Supply
    • Investigational Drug Supply
    • Special Access Program
  • News & Media
    • Blog
    • Press Releases
    • In The News
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEDAR
    • Governance
    • FAQs
  • Contact
  • Careers
  • Search

Press Releases

News & Media

News & Media

  • Blog
  • Press Releases
  • In The News
Aug 24, 2021 3:30pm EDT

Mydecine Innovations Group Announces Mailing of Management Information Circular and Provides Update on Spin-Out of U.S. Cannabis Assets

Aug 18, 2021 7:30am EDT

Mydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns Hopkins University School of Medicine

Aug 16, 2021 4:55pm EDT

Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update

Jul 28, 2021 7:30am EDT

Mydecine to Participate in Upcoming Investor Events in August 2021

Jul 21, 2021 7:30am EDT

Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds

Jul 13, 2021 7:30am EDT

Mydecine Innovations Group Announces Launch of Mindleap Version 2.0

Jun 24, 2021 7:30am EDT

Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004

Jun 23, 2021 7:30am EDT

Mydecine to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th

Jun 16, 2021 7:30am EDT

Mydecine Unveils Artificial Intelligence Drug Discovery Program

Jun 08, 2021 7:30am EDT

Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms

rss_feed News RSS
  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • arrow_forward

Sign up for our Newsletter!

twitter Linkedin Instagram
©2022 Mydecine Innovations Group Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap